Coronavirus Vaccine | Oxford's COVID-19 vaccine faces more questions after AstraZeneca admits error: Report

Coronavirus Vaccine | Oxford's COVID-19 vaccine faces more questions after AstraZeneca admits error: Report

Jagran English

New Delhi | Jagran News Desk: AstraZeneca Plc and the University of Oxford are facing questions about their COVID-19 vaccine and whether regulators would quickly authorise its emergency use after the pharma company acknowledged an error in the vaccine dosage received by some participants and other irregularities and omissions, according to a media report.

AstraZeneca and the University of Oxford announced this week that their inexpensive, easy-to-produce coronavirus vaccine appeared effective, with the average efficacy of about 70 per cent.

However, AstraZeneca has acknowledged a key mistake in the vaccine dosage received by some study participants, the New York Times said in a report.

Disclaimer: This is an automatically aggregated article/story by a computer program and has not been created or edited by Newsdig.in.

World COVID19 Meter

99196909

Cases

71012013

Recovered

2126577

Deaths
Last updated: GMT
Advt
Advt
Advt
sitemap Disclaimer
Newsdig.in 2019